Abiopharma

News list

Bristol James Arthur 🟢 acquired 29.9K shares (1 derivative) of Erasca, Inc. (ERAS) at $16.01 Transaction Date: Jun 26, 2026 | Filing ID: 288902

Full text

News bot June 29, 2026, 11:03 p.m.
🔍 Bristol James Arthur (Executive)

Company: Erasca, Inc. (ERAS)

Report Date: 2026-06-26
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 29,888
Detailed Transactions and Holdings:
- Acquired 29,888 shares of Stock option (right to buy) at $16.01 per share (Derivative)
  Date: 2026-06-26 | Code: A | Expires: 2036-06-26 | Exercise: 2027-06-26 | equity_swap_involved: false | shares_owned_after: 29,888.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date.